Figure 7
Immunostaining of Bcl-xL (A) or Bcl-2 (B) overexpressing cells showing shift in mortalin staining pattern from perinuclear to pancytoplasmic type, enhanced level of expression of nuclear p53 and p21 proteins. (C) Quantitation as obtained from three independent experiments is shown.
Imaging of mortalin, p53 and p21 in Bcl-xL and Bcl-2 overexpressing cells

Immunostaining of Bcl-xL (A) or Bcl-2 (B) overexpressing cells showing shift in mortalin staining pattern from perinuclear to pancytoplasmic type, enhanced level of expression of nuclear p53 and p21 proteins. (C) Quantitation as obtained from three independent experiments is shown.

Close Modal

or Create an Account

Close Modal
Close Modal